Trial Outcomes & Findings for Implementing HEARTS in Guatemala (NCT NCT06080451)
NCT ID: NCT06080451
Last Updated: 2025-06-19
Results Overview
Feasibility will be assessed among Ministry of Health (MOH) participants through the four-item Feasibility of Intervention Measure (FIM) Questionnaire and semi-structured interviews. A Spanish-language version of the FIM will be adapted for this project. Scores will be on a scale of 1 to 5, with 1 being the worst and 5 being the best. The average score for each participant will be used.
COMPLETED
NA
964 participants
6 months
2025-06-19
Participant Flow
Providers not considered Enrolled
Participant milestones
| Measure |
HEARTS Implementation - Patients
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the patients whose health markers will be monitored through the study.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Overall Study
STARTED
|
964
|
40
|
|
Overall Study
Completed Provider Survey (Not Applicable to Patient Arm)
|
0
|
20
|
|
Overall Study
COMPLETED
|
964
|
20
|
|
Overall Study
NOT COMPLETED
|
0
|
20
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Age data was only collected for the patient arm and not for the provider arm.
Baseline characteristics by cohort
| Measure |
HEARTS Implementation - Patients
n=964 Participants
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the patients whose health markers will be monitored through the study.
Integrated Diabetes and Hypertension Primary Care Model: The intervention consists of five components that align with the World Health Organization Technical Package for Cardiovascular Disease Management in primary Health Care.
1. Training health workers on diabetes and hypertension treatment protocols
2. Team-based care and task sharing
3. Strengthening access to medications and diagnostics
4. Electronic medical record system and registry
5. Systems monitoring and feedback of key indicators
|
HEARTS Implementation - Providers
n=20 Participants
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
Integrated Diabetes and Hypertension Primary Care Model - Providers: The intervention consists of five components that align with the World Health Organization Technical Package for Cardiovascular Disease Management in primary Health Care.
1. Training health workers on diabetes and hypertension treatment protocols
2. Team-based care and task sharing
3. Strengthening access to medications and diagnostics
4. Electronic medical record system and registry
5. Systems monitoring and feedback of key indicators
Health care providers will administer this intervention to patient participants and will report on their experience.
|
Total
n=984 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
55.2 years
n=964 Participants • Age data was only collected for the patient arm and not for the provider arm.
|
—
|
55.2 years
n=964 Participants • Age data was only collected for the patient arm and not for the provider arm.
|
|
Sex: Female, Male
Female
|
760 Participants
n=964 Participants • Sex data was only collected for the patient arm and not for the provider arm.
|
—
|
760 Participants
n=964 Participants • Sex data was only collected for the patient arm and not for the provider arm.
|
|
Sex: Female, Male
Male
|
204 Participants
n=964 Participants • Sex data was only collected for the patient arm and not for the provider arm.
|
—
|
204 Participants
n=964 Participants • Sex data was only collected for the patient arm and not for the provider arm.
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
474 Participants
n=964 Participants • Ethnicity data was only collected for the patient arm and not for the provider arm.
|
—
|
474 Participants
n=964 Participants • Ethnicity data was only collected for the patient arm and not for the provider arm.
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
486 Participants
n=964 Participants • Ethnicity data was only collected for the patient arm and not for the provider arm.
|
—
|
486 Participants
n=964 Participants • Ethnicity data was only collected for the patient arm and not for the provider arm.
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
4 Participants
n=964 Participants • Ethnicity data was only collected for the patient arm and not for the provider arm.
|
—
|
4 Participants
n=964 Participants • Ethnicity data was only collected for the patient arm and not for the provider arm.
|
|
Region of Enrollment
Guatemala
|
964 participants
n=964 Participants
|
20 participants
n=20 Participants
|
984 participants
n=984 Participants
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: This outcome measure only applies to the Providers group. No data was collected for the Patients group. Only 20 providers responded to this survey.
Feasibility will be assessed among Ministry of Health (MOH) participants through the four-item Feasibility of Intervention Measure (FIM) Questionnaire and semi-structured interviews. A Spanish-language version of the FIM will be adapted for this project. Scores will be on a scale of 1 to 5, with 1 being the worst and 5 being the best. The average score for each participant will be used.
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=20 Participants
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Score on Feasibility of Intervention Measure (FIM) Questionnaire
|
5.0 score on a scale
Interval 5.0 to 5.0
|
—
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: This outcome measure only applies to the Patients group. No data was collected for the Providers group.
This study will be working with two different health districts, one in the west and the other in the east. This measure is the number of districts that met enrollment goals for patients for patients with diabetes (at least 25) and also for patients with hypertension (at least 25). A given patient may have both diabetes and hypertension and thus count toward each benchmark
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=2 Districts
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Number of Target Health Districts That Met Enrollment Goals
|
2 Districts
|
—
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: Only 20 providers responded to this survey. This measure only applies to the provider arm.
Acceptability will be assessed among providers through the four-item Acceptability Intervention Measure (AIM) Questionnaire and semi-structured interviews. A Spanish-language version of the AIM will be adapted for this project. Scores will be on a scale of 1 to 5, with 1 being the worst and 5 being the best. The average score for each participant will be used.
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=20 Participants
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Score on Acceptability of Intervention Measure (AIM) Questionnaire
|
5.0 score on a scale
Interval 4.8 to 5.0
|
—
|
PRIMARY outcome
Timeframe: 3 monthsProportion of patient participants with subsequent follow-up visit within 3 months in both regions combined.
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=964 Participants
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Proportion of Patient Participants With Subsequent Follow-up Visit Within 3 Months
|
36 percentage of patients
|
—
|
SECONDARY outcome
Timeframe: 6 monthsNumber of patients receiving hypertension medication treatment in the 6th month of the study.
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=964 Participants
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Hypertension Treatment Rate
|
197 Participants
|
—
|
SECONDARY outcome
Timeframe: 6 monthsNumber of patients receiving diabetes medication treatment in the 6th month of the trial..
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=964 Participants
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Diabetes Treatment Rate
|
108 Participants
|
—
|
SECONDARY outcome
Timeframe: 6 monthsPopulation: Monitoring system only captured data from 39 participants and failed to capture data for other participants
Proportion achieving glycemic control (fasting blood glucose \<115 mg/dl or random blood glucose \<160 mg/dl) among patients with diabetes
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=39 Participants
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Proportion of Patient Participants Achieving Glycemic Control
|
41 percent
|
—
|
SECONDARY outcome
Timeframe: 6 monthsPopulation: The monitoring system was incompletely utilized and only captured this data for 83 participants
Proportion achieving control of blood pressure (\<130/80 mmHg) among patients with hypertension. This information will be taken from electronic medical records.
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=83 Participants
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Proportion Achieving Control of Blood Pressure
|
50.6 percent
|
—
|
SECONDARY outcome
Timeframe: 6 monthsPopulation: One of the eleven initially planned health facilities declined to participate in the study.
Count and percentage of participating health facilities who enrolled at least one patient with hypertension or diabetes.
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=10 Clinics
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Adoption
|
10 Clinics
|
—
|
SECONDARY outcome
Timeframe: 6 monthsNumber of health workers in each district attending all training sessions
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=40 Participants
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Fidelity - Health Worker Training
District 1
|
20 Participants
|
—
|
|
Fidelity - Health Worker Training
District 2
|
20 Participants
|
—
|
SECONDARY outcome
Timeframe: 6 monthsPopulation: This group is of Clinics, not of participants. One of the eleven initially planned facilities declined to participate in this study.
Proportion of primary health facilities conducting at least one care coordination meeting
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=10 Clinics
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Fidelity - Team-based Care and Task Sharing
|
10 Clinics
|
—
|
SECONDARY outcome
Timeframe: 6 monthsPopulation: One of the eleven initially planned facilities declined to participate in this study.
Months in which primary health facilities had monthly availability of Ministry of Health medications and diagnostics for diabetes and hypertension. Drugs include antihypertensive medications (hydrochlorothiazide, enalapril, losartan) and oral hypoglycemic agents (metformin and glimepiride). Diagnostics including blood pressure cuffs and monitors, glucometers, lancets, and glucose strips. Data is reported in "clinic-months", which is the sum number of months that each clinic reported monthly availability of medications and diagnostics (n=60 total clinic months(10 clinics x 6 months)).
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=10 Clinics
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Fidelity - Access to Medicines and Diagnostics
|
49 clinic-months
|
—
|
SECONDARY outcome
Timeframe: 6 monthsPopulation: Number of patient visits
Proportion of patient visits captured in DHIS2 during the study compared to comprehensive records in the Ministry of Health's Health Management Information System. Data was collected at the end of the 6th month study. Data is presented as percent of visits that were captured.
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=1374 Visits
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Fidelity - Facility-based Electronic Monitoring Tool
|
7.6 percentage of visits
|
—
|
SECONDARY outcome
Timeframe: 6 monthsPopulation: Questionnaire was given to the provider arm only. 20 of the 40 providers responded to this survey.
Average score on the System Usability Scale questionnaire. Scores have a range of 0 (worst) to 100 (best). Questionnaire was given to the provider arm only.
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=20 Participants
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Usability
|
67.7 units on a scale
Standard Deviation 23.5
|
—
|
SECONDARY outcome
Timeframe: 6 monthsPopulation: 20 of the 40 provider participants responded to this survey.
Mean score on a sustainability questionnaire. Questionnaire was created by combining 6 questions from the Program Sustainability Assessment Tool (PSAT) and Clinical Sustainability Assessment Tools (CSAT). Scores range from 1 (worst) to 7 (best). The data reported is the median of the mean scores for each of the health providers.
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=20 Participants
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Sustainability
|
5.3 units on a scale
Interval 4.8 to 5.9
|
—
|
SECONDARY outcome
Timeframe: 6 monthsPopulation: While this outcome measure was part of the original plan for the study, implementation of monitoring this outcome failed and data was only collected for 72 patients. This outcome measure did not apply to the provider's arm.
Mean systolic blood pressure among patients with hypertension
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=72 Participants
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Mean Systolic Blood Pressure
|
141.7 mmHg
Standard Deviation 18.5
|
—
|
SECONDARY outcome
Timeframe: 6 MonthsPopulation: While this outcome measure was part of the original plan for the study, implementation of monitoring this outcome failed and data was only collected for 71 patients. This outcome measure did not apply to the provider's arm. While Systolic pressure was recorded for 72 participants, diastolic pressure was not recorded from one of these participants due to an unknown error at the clinic.
Mean diastolic blood pressure among patients with hypertension
Outcome measures
| Measure |
HEARTS Implementation - Providers
n=71 Participants
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
HEARTS Implementation - Providers
A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.
|
|---|---|---|
|
Mean Diastolic Blood Pressure
|
81.5 mmHg
Standard Deviation 11.2
|
—
|
SECONDARY outcome
Timeframe: 6 monthsPopulation: While this outcome measure was part of the original plan for the study, implementation of monitoring this outcome failed and no data was collected due to physicians' declination to use the software. This measure only applied to the patients arm.
Proportion of clinical visits that are guideline concordant according to study team's audit of least 25% of patient visits
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 6 monthsPopulation: While this outcome measure was part of the original plan for the study, implementation of monitoring this outcome failed and no data was collected due to physicians' declination to use the software.
Proportion of quarterly reports viewed by health district administrators
Outcome measures
Outcome data not reported
Adverse Events
HEARTS Implementation - Patients
HEARTS Implementation - Providers
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place